Patients with esophageal cancer had significantly higher levels of s-PCSK9-Ag than HDs (p = 0.002), but no significant difference was observed between patients with gastric cancer and HDs (p = 0.057) (Figure 4A). This evidence concerns the gene PCSK9 and esophageal cancer.